Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis

被引:0
|
作者
Dengming Lai
Jing Tang
Linsong Chen
Erica K. Fan
Melanie J. Scott
Yuehua Li
Timothy R. Billiar
Mark A. Wilson
Xiangming Fang
Qiang Shu
Jie Fan
机构
[1] The Children’s Hospital of Zhejiang University School of Medicine,Department of Thoracic and Cardiovascular Surgery
[2] University of Pittsburgh School of Medicine,Department of Surgery
[3] Southern Medical University,Department of Anesthesiology, Nanfang Hospital
[4] Tongji University School of Medicine,Department of Thoracic Surgery, Shanghai Pulmonary Hospital
[5] University of Pittsburgh School of Arts and Science,Research and Development
[6] Veterans Affairs Pittsburgh Healthcare System,McGowan Institute for Regenerative Medicine
[7] University of Pittsburgh,Department of Anesthesiology and Intensive Care Unit, The First Affiliated Hospital
[8] Zhejiang University School of Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Group 2 innate lymphoid cells (ILC2) are one of three subgroups of innate lymphoid cells (ILC1, ILC2, and ILC3), and the major ILC population detected in the lungs. The function of ILC2 in the regulation of lung inflammation remains unclear. In the current study, we explored an important role of ILC2 in protecting lung endothelial cell (EC) from pyroptosis in sepsis-induced acute lung inflammation and the underlying mechanism. Using a cecal ligation and puncture (CLP) mouse sepsis model, we demonstrated that IL-33, which is released in response to sepsis, acting through its receptor ST2 mediates ILC2 expansion in the lungs. We further showed that the increased ILC2 in the lungs secrete IL-9, which in turn prevents lung EC from undergoing pyroptosis, a pro-inflammatory cell death form, by attenuating caspase-1 activation. These findings suggest a previously unidentified innate pathway that negatively regulates lung inflammation following sepsis.
引用
收藏
相关论文
共 50 条
  • [21] Group 2 innate lymphoid cells in human asthma
    Iwata, Arifumi
    Toda, Yosuke
    Furuya, Hiroki
    Nakajima, Hiroshi
    ALLERGOLOGY INTERNATIONAL, 2023, 72 (02) : 194 - 200
  • [22] The Fate of Activated Group 2 Innate Lymphoid Cells
    Matha, Laura
    Martinez-Gonzalez, Itziar
    Steer, Catherine A.
    Takei, Fumio
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [23] Group 2 innate lymphoid cells in nasal polyposis
    Stevens, Whitney W.
    Kato, Atsushi
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 126 (02) : 110 - 117
  • [24] Group 2 Innate Lymphoid Cells in Health and Disease
    Kim, Brian S.
    Artis, David
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2015, 7 (05): : 1 - 15
  • [25] Group 2 Innate Lymphoid Cells in Airway Diseases
    Kato, Atsushi
    CHEST, 2019, 156 (01) : 141 - 149
  • [26] Development and function of group 2 innate lymphoid cells
    Walker, Jennifer A.
    McKenzie, Andrew N. J.
    CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (02) : 148 - 155
  • [27] Immunological Memory of Group 2 Innate Lymphoid Cells
    Martinez-Gonzalez, Itziar
    Matha, Laura
    Steer, Catherine A.
    Takei, Fumio
    TRENDS IN IMMUNOLOGY, 2017, 38 (06) : 423 - 431
  • [29] New Kids on the Block Group 2 Innate Lymphoid Cells and Type 2 Inflammation in the Lung
    Halim, Timotheus Y. F.
    McKenzie, Andrew N. J.
    CHEST, 2013, 144 (05) : 1681 - 1686
  • [30] Group 2 innate lymphoid cells protect mouse heart from myocardial infarction injury via interleukin 5, eosinophils, and dendritic cells
    Liu, Tianxiao
    Meng, Zhaojie
    Liu, Jing
    Li, Jie
    Zhang, Yuanyuan
    Deng, Zhiyong
    Luo, Songyuan
    Wang, Minjie
    Huang, Qin
    Zhang, Shuya
    Fendt, Pauline
    Devouassoux, Julie
    Li, Dazhu
    McKenzie, Andrew Neil James
    Nahrendorf, Matthias
    Libby, Peter
    Guo, Junli
    Shi, Guo Ping
    CARDIOVASCULAR RESEARCH, 2023, 119 (04) : 1046 - 1061